Advancements in Kidney Care through Genetic Testing
The National Kidney Foundation (NKF) held a groundbreaking summit focused on integrating genetic testing into routine kidney care. Taking place in Dallas, TX, from September 18-19, 2026, the event gathered nephrologists, genetic counselors, researchers, patients, and advocates to explore how genetic testing can transform kidney health management.
Objectives of the Summit
The primary goals of the summit were to promote responsible genetic testing in routine nephrology practices, encourage collaboration between health professionals, and broaden the understanding of current guidelines and their implications in clinical settings. The participants exchanged practical insights on incorporating genetic testing effectively into patient care, aiming to ensure that more patients could receive accurate diagnoses and access customized care options based on their genetic profiles.
Key Themes and Insights
A significant takeaway from the summit highlighted the necessity for genetic testing to extend beyond a few specialized centers. It was emphasized that community nephrologists play a crucial role in recognizing patients who would benefit from genetic testing. They can become advocates for kidney genetics by not only identifying potential candidates but also guiding them through the testing process, interpreting results, and coordinating ongoing care.
Dr. Meyeon Park, co-chair of the summit and Professor of Clinical Medicine at the University of California, San Francisco, stated, "Genetic testing is becoming an increasingly important part of kidney care because it can replace uncertainty with answers and offer clearer information for clinical decisions." He stressed the importance of patient and family involvement in advancing genetic science into practical applications.
Transforming Genetic Testing from Specialty to Routine
The summit consisted of various sessions that addressed the establishment of systematic approaches to incorporating genetic testing into nephrology practices. Topics included identifying patients in need, obtaining informed consent, sample collection, communicating results, and determining when to involve genetic specialists. The consensus was clear: nephrologists need not become geneticists to advocate for genetic testing. Simple systems within practices can facilitate the ordering of tests and reviewing of results to make genetic testing part of everyday nephrology.
Moreover, uncertainties in test results were also discussed, particularly concerning variants of uncertain significance. The summit encouraged sharing clinical details and family testing to aid laboratories in interpreting these results over time. Additionally, participants addressed critical factors like equitable access, privacy, insurance issues, and the significance of clinical data systems that can enhance research and clinical trials.
Dr. Christopher Kwoh, another co-chair of the summit, echoed the importance of nephrologists acting as champions of kidney genetics, emphasizing that understanding when to recommend genetic testing can bring life-changing information to patients and their families.
Patient Perspectives on Genetic Testing
Patient advocates at the summit shared powerful narratives illustrating the long-lasting effects of inherited kidney diseases on families. Many spoke candidly about the emotional turmoil that accompanies uncertain diagnoses and the difficult decisions regarding testing family members, managing treatment plans, and leveraging health care systems that may not always prioritize their needs.
Katie Reed, a kidney transplant survivor and advocate, urged for a patient-centered approach. “This isn’t just about the diagnosis. It’s about treating the whole person and recognizing how their genetic condition affects their family and future,” she noted. Her insights shed light on the disparities faced by rural populations and those lacking access to necessary health services. Reed emphasized the importance of reaching out to underrepresented communities in healthcare to ensure equity in genetic testing and subsequent care.
Joshua Albright, another advocate, shared his personal journey with kidney disease, emphasizing the hope brought by advancements in treatment options. He stressed that new therapies could lead to better quality of life, moving beyond traditional methods like dialysis and steroids, thus paving the way for more hopeful outcomes for future patients.
The Future of Kidney Genetic Care
The summit concluded with discussions around the rapid advancements in kidney genetics. The trajectory of this field has evolved with innovations like next-generation sequencing that assesses numerous genes simultaneously, paving the way for genome-wide association studies that link genetic variations with disease prevalence.
The use of polygenic risk scores emerged as a promising strategy for evaluating kidney disease risk across broader populations. By consolidating genetic results and biological data, researchers aim to uncover the intricacies of kidney disease causation, preparing the ground for more personalized therapeutic approaches.
Moving forward, the NKF intends to leverage insights from this summit to foster ongoing education, facilitate collaboration, and ensure seamless integration of genetic testing in kidney care. This initiative exemplifies NKF's commitment to promoting awareness and cooperation among nephrologists, genetic counselors, patients, and researchers to forge a future where genetic information enhances patient care.
For additional details regarding the summit, please visit the NKF's official page.
About Kidney Disease
Chronic kidney disease (CKD) affects approximately 1 in 7 adults in the United States, most of whom remain unaware of their condition. CKD risk factors include diabetes, high blood pressure, and genetic predisposition, with certain demographics facing higher risks. Awareness and early diagnosis are crucial in managing CKD effectively.
About the National Kidney Foundation
The National Kidney Foundation is dedicated to saving lives by eliminating preventable kidney diseases and addressing disparities in kidney care. For more information, visit
www.kidney.org.